Danazol (AvKARE, Inc.)
Welcome to the PulseAid listing for the Danazol drug offered from AvKARE, Inc.. This Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
NON-PROPRIETARY NAME: | Danazol |
SUBSTANCE NAME: | DANAZOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-02-23 |
END MARKETING DATE: | 0000-00-00 |
Danazol HUMAN PRESCRIPTION DRUG Details:
Item Description | Danazol from AvKARE, Inc. |
LABELER NAME: | AvKARE, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2016-02-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42291-243_5df42da0-05dd-97a8-a68b-332bb243f3b2 |
PRODUCT NDC: | 42291-243 |
APPLICATION NUMBER: | ANDA074582 |
Other DANAZOL Pharmaceutical Manufacturers / Labelers: